Topical issues in venous thromboembolism

Drugs

Volumn 70, Issue SUPPL. 2, 2010, Pages 11-18

  Rico, José Ignacio Abad ^a   Pitarch, Juan Vicente Llau ^b   Páramo, José ^c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; APIXABAN; DABIGATRAN ETEXILATE; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; RIVAROXABAN; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; ELECTRONIC SENSOR; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HUMAN; ORTHOPEDIC SURGERY; PHLEBOGRAPHY; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; CHILD; CLINICAL ALARMS; DRUG MONITORING; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 78650486593     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/1158582-S0-000000000-00000     Document Type: Review

References (36)

1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun; 133 (6 Suppl.): 381S-453S
2. NICE. Venous thromboembolism: reducing the risk. 2010 [cited 2010 24 Feb]. Available from: http://www.nice.org.uk/nicemedia/pdf/CG92NICEGuidance.pdf
3. American Academy of Orthopaedic Surgeons. American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty. Adopted by the American Academy of Orthopedic Surgeons Board of Directors May 2007. 2007 [cited 2009 4 November]. Available from: www.aaos.org/research/guidelines/PE-guideline.pdf
4. Snow V, Qaseem A, Barry P, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2007 Feb 6; 146 (3): 204-10 (Pubitemid 351650634)
5. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008 Sep; 29 (18): 2276-315
6. Breckenridge A. Oral anticoagulant drugs: pharmacokinetic aspects. Semin Hematol 1978 Jan; 15 (1): 19-26
7. O'Reilly RA. Vitamin K and the oral anticoagulant drugs. Annu Rev Med 1976; 27: 245-61
8. Kelly JG, O'Malley K. Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet 1979 Jan-Feb; 4 (1): 1-15
9. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun; 133 (6 Suppl.): 160S-98S (Pubitemid 351892967)
10. Christensen TD. Self-management of oral anticoagulant therapy: a review. J Thromb Thrombolysis 2004 Oct; 18 (2): 127-43
11. Rodger M, Bredeson C, Wells PS, et al. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis. Can Med Assoc J 1998 Oct 20; 159 (8): 931-8
12. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005 Oct 15; 106 (8): 2710-15
13. Schulman S, Beyth RJ, Kearon C, et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun; 133 (6 Suppl.): 257S-98S (Pubitemid 351892969)
14. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun; 133 (6 Suppl.): 454S-545S (Pubitemid 351892971)
15. Marlovits S, Striessnig G, Schuster R, et al. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study. Arthroscopy 2007 Jul; 23 (7): 696-702
16. Torholm C, Broeng L, Jorgensen PS, et al. Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery. A placebo controlled study. J Bone Joint Surg Br 1991 May; 73 (3): 434-8
17. Gómez-Outes A, Lecumberri R, Pozo C, et al. New anticoagulants: focus on venous thromboembolism. Curr Vasc Pharmacol 2009 Jul; 7 (3): 309-29
18. Bauer KA, Eriksson BI, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.N Engl J Med 2001 Nov 1; 345 (18): 1305-10
19. GlaxoSmithKline. Arixtra Prescribing Information. 2010 [cited 2010 Aug 12]. Available from: http://us.gsk.com/products/assets/us-arixtra.pdf
20. Walenga JM, Adiguzel C. Drug and dietary interactions of the new and emerging oral anticoagulants. Int J Clin Pract 2010 Jun; 64 (7): 956-67
21. Bergqvist D, Hull RD. Effective thromboprophylaxis administered close to the time of major orthopedic surgery: a review. Am J Orthop (Belle Mead NJ) 2006 May; 35 (5): 226-30
22. Warwick D. New concepts in orthopaedic thromboprophylaxis. J Bone Joint Surg Br 2004 Aug; 86 (6): 788-92
23. Samama CM, Albaladejo P, Benhamou D, et al. Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines. Eur J Anaesthesiol 2006 Feb; 23 (2): 95-116
24. Monreal M, Vignoli A, Lecumberri R, et al. Bemiparin in oncology. Drugs 2010; 70 (2 Suppl.): 35-42
25. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008 Feb 2; 371 (9610): 387-94
26. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005 Mar 10; 352 (10): 969-77
27. Lecumberri R, Marqués M,Díaz-Navarlaz MT, et al. Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients. Thromb Haemost 2008 Oct; 100 (4): 699-704
28. Monreal M, Kakkar AK, Caprini JA, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2004 Nov; 2 (11): 1892-8
29. Galanter WL, Thambi M, Rosencranz H, et al. Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. Am J Health Syst Pharm 2010 Aug; 67 (15): 1265-73
30. Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009 Apr 28; 119 (16): 2196-201
31. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in nonsurgical patients. J Thromb Haemost 2005 Apr; 3 (4): 692-4
32. Thabut G, Estellat C, Boutron I, et al. Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism. Eur Heart J 2006 Jan; 27 (2): 227-36
33. Haas SB, Barrack RL, Westrich G, et al. Venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 2008 Dec; 90 (12): 2764-80
34. Eikelboom JW, Karthikeyan G, Fagel N, et al. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest 2009 Feb; 135 (2): 513-20
35. Yang J, Paredes N, Chan AK. Antithrombotic therapy in children with venous thromboembolism. Hamostaseologie 2009 Jan; 29 (1): 80-7
36. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 Jun; 133 (6 Suppl.): 887S-968S